Health ❯ Cancer

Multiple Myeloma

Diagnosis Treatment Symptoms Health Challenges Immunotherapy Patti Scialfa Patient Outcomes Treatment Options Chronic Illness Immune System Personal Loss Survival Rate Treatment Advances Ferroptosis Clinical Research Early Diagnosis Bone Marrow Lung Cancer Immunology Jan Vandersloot Remission Autologous Stem Cell Transplant Diagnostics Prognosis Treatment Challenges Research Illness Bone Marrow Cancer Stage 3 Cancer Genomic Risk Assessment Clinical Presentation Causes Biological Mechanisms

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

The purchase secures full control of anito-cel, a BCMA-directed cell therapy under FDA review with a December 23 action date.

U.S. Cohort Study Finds Men Present With More Advanced Multiple Myeloma

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

New Genomic Score Enhances Prediction of Multiple Myeloma Progression